SEC Form 4 · accession 0001179110-19-002133
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis Levy
Officer — Chief Medical Officer
Period of report
Feb 15, 2019
Accepted (ET)
Feb 20, 2019 · 3:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 15, 2019 | M | 1,285 | $35.45 | A | 3,756 | D | |
| Common StockF1 | Feb 15, 2019 | S | 1,285 | $67.21 | D | 2,471 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $35.45 | Feb 15, 2019 | M | 1,285 | D | — | Jul 14, 2027 | Common Stock | 1,285 | 37,253 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 14, 2018.
- F2The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.